Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14
The FDA approved Zepbound for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity, to be used in combination with a reduced-calorie diet and increased physical activity
Symptoms include dizziness, sweating, confusion, and, in severe cases, loss of consciousness
By consistently tracking your blood sugar levels and attending routine medical appointments at our facility, you enable our providers to closely evaluate your progress, assess the effectiveness of your treatment, and make timely adjustments when necessary
Use a 1.5mL syringe or split the dose into two separate draws
US$ 29.15
US$ 29.68
US$ 29.48
US$ 22.98
US$ 24.25
